Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Relebactam
Global Relebactam Supply, Demand and Key Producers, 2024-2030
22 Apr 2024
Pharma & Healthcare
Relebactam is a new beta-lactamase inhibitor with broad-spectrum anti-beta-lactamase activity, including class A (extended-spectrum beta-lactamase and KPC) and class C (AmpC enzyme). It can restore the sensitivity of strains to beta-lactam antibiotics, thereby enhancing the therapeutic effect of antibiotics.
USD4480.00
Add To Cart
Global Relebactam Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
22 Apr 2024
Pharma & Healthcare
Relebactam is a new beta-lactamase inhibitor with broad-spectrum anti-beta-lactamase activity, including class A (extended-spectrum beta-lactamase and KPC) and class C (AmpC enzyme). It can restore the sensitivity of strains to beta-lactam antibiotics, thereby enhancing the therapeutic effect of antibiotics.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Relebactam
Total: 2 records, 1 pages
Relebactam is a new beta-lactamase inhibitor with broad-spectrum anti-beta-lactamase activity, including class A (extended-spectrum beta-lactamase and KPC) and class C (AmpC enzyme). It can restore the sensitivity of strains to beta-lactam antibiotics, thereby enhancing the therapeutic effect of antibiotics.
USD4480.00
Add To Cart
Relebactam is a new beta-lactamase inhibitor with broad-spectrum anti-beta-lactamase activity, including class A (extended-spectrum beta-lactamase and KPC) and class C (AmpC enzyme). It can restore the sensitivity of strains to beta-lactam antibiotics, thereby enhancing the therapeutic effect of antibiotics.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>